Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial.

Conclusion: The early administration of oral bromhexine reduces the ICU transfer, intubation, and the mortality rate in patients with COVID-19. This affordable medication can easily be administered everywhere with a huge positive impact(s) on public health and the world economy. Altogether, the verification of our results on a larger scale and different medical centers is strongly recommended. Trial Registration: IRCT202003117046797N4; https://irct.ir/trial/46969. PMID: 32983936 [PubMed]
Source: BioImpacts - Category: Research Tags: Bioimpacts Source Type: research